Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCSW) Research & Development (2021 - 2025)

Historic Research & Development for HeartSciences (HSCSW) over the last 5 years, with Q4 2025 value amounting to $727026.0.

  • HeartSciences' Research & Development fell 3936.22% to $727026.0 in Q4 2025 from the same period last year, while for Oct 2025 it was $3.7 million, marking a year-over-year decrease of 736.46%. This contributed to the annual value of $4.4 million for FY2025, which is 5237.18% up from last year.
  • According to the latest figures from Q4 2025, HeartSciences' Research & Development is $727026.0, which was down 3936.22% from $997206.0 recorded in Q3 2025.
  • Over the past 5 years, HeartSciences' Research & Development peaked at $1.4 million during Q2 2022, and registered a low of $401114.0 during Q3 2021.
  • Its 5-year average for Research & Development is $802849.5, with a median of $742164.5 in 2023.
  • In the last 5 years, HeartSciences' Research & Development plummeted by 6057.66% in 2023 and then surged by 11655.97% in 2024.
  • Quarter analysis of 5 years shows HeartSciences' Research & Development stood at $545773.0 in 2021, then soared by 55.55% to $848976.0 in 2022, then decreased by 10.8% to $757303.0 in 2023, then soared by 58.32% to $1.2 million in 2024, then tumbled by 39.36% to $727026.0 in 2025.
  • Its Research & Development was $727026.0 in Q4 2025, compared to $997206.0 in Q3 2025 and $929091.0 in Q2 2025.